Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Encision's operating cash flow for the twelve months ending Sep 30, 2025 was -$489.80K, down 244.0% year over year. For fiscal 2025 it was -$54.95K, down 138.1% from the year before. The highest annual figure on record is $419.44K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$54.95K | -138.1% |
| FY2024 | Mar 31, 2024 | $144.39K | – |
| FY2023 | Mar 31, 2023 | -$861.49K | – |
| FY2022 | Mar 31, 2022 | -$444.43K | -302.1% |
| FY2021 | Mar 31, 2021 | $219.95K | – |
| FY2020 | Mar 31, 2020 | -$229.48K | – |
| FY2019 | Mar 31, 2019 | -$127.24K | -130.3% |
| FY2018 | Mar 31, 2018 | $419.44K | +1732.6% |
| FY2017 | Mar 31, 2017 | $22.89K | – |
| FY2016 | Mar 31, 2016 | -$165.84K | – |
| FY2015 | Mar 31, 2015 | -$1.43M | -1388.4% |
| FY2014 | Mar 31, 2014 | $111.21K | – |
| FY2013 | Mar 31, 2013 | -$315.79K | -297.8% |
| FY2012 | Mar 31, 2012 | $159.64K | -18.6% |
| FY2011 | Mar 31, 2011 | $196.17K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$126.64K | -268.5% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$115.51K | -198.3% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$201.80K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$45.85K | -129.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $75.17K | +72.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $117.53K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$10.96K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $158.36K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $43.47K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$46.47K | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$124.34K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$399.63K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$281.48K | -201.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$56.03K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$427.03K | -484.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$165.58K | -160.9% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $276.23K | +17825.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$128.05K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $110.95K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $271.86K | +71.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.54K | -98.2% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$164.41K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$184.42K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $158.38K | +143.8% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $87.55K | -57.2% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$290.99K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$254.55K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $64.97K | -46.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $204.39K | -23.3% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$142.05K | -232.1% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$74.96K | -427.6% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $120.28K | -26.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $266.61K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $107.52K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $22.88K | -77.4% |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $162.46K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$34.52K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$127.93K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $101.36K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$207.30K | – |
See a number that looks wrong?